Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-03-14
1998-03-17
Dean, Karen A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514521, 514298, 514667, 514594, 514354, 514245, 514369, 514241, 514219, 514450, 514712, 514452, 501123, 549264, 424405, 568363, 568592, A01N 4382
Patent
active
057287198
ABSTRACT:
The present invention is a method for controlling ectoparasites. More particularly, the invention relates to a method of treatment in which the warm blooded animal is dosed with an ovicidally effective amount of a heterocyclic nitrogen compound selected from the group represented by the formula: ##STR1## wherein R.sub.1, is either one of the following groups: ##STR2## in which R.sub.7, R.sub.8, R.sub.9, R.sub.10, R.sub.11, R.sub.12, R.sub.13, R.sub.14, R.sub.15, R.sub.16, and R.sub.17 are, the same or different, each a hydrogen atom, a halogen atom, a C.sub.1 -C.sub.4 alkoxy group, a C.sub.1 -C.sub.4 alkylthio group, a trifluoro methyl group or a vitro group, R.sub.18, R.sub.19, R.sub.20 and R.sub.21 are, the same or different, each a hydrogen atom or a methyl group, k is an integer of 0 to 1 and 1 is an integer of 0 to 3; R.sub.2 and R.sub.3 are, the same or different, each a hydrogen atom, a halogen atom or a methyl group; R.sub.4 is a halogen atom or a methyl group; R.sub.5 and R.sub.6 are, the same or different, each a hydrogen atom, a halogen atom, a C.sub.1 -C.sub.4 haloalkyl group or a C.sub.1 -C.sub.4 haloalkoxy group; X, Y and Z are, the same or different, each an oxygen atom, a sulfur atom or a methylene group, m is an integer of 0 to 4, and n is an integer of 0 to 2, which is transmitted to the ectoparasite by the animal's blood. In a further embodiment, a compound selected from the group consisting of ivermectin, milbemycin, milbemycin oxime, moxidectin and avermectin and avermectin derivatives.
REFERENCES:
patent: 3748356 (1973-07-01), Wellinga et al.
patent: 3950360 (1976-04-01), Aoki et al.
patent: 3962458 (1976-06-01), Schrider
patent: 3987102 (1976-10-01), Karrer
patent: 3987108 (1976-10-01), Karrer
patent: 3988477 (1976-10-01), Karrer
patent: 4006236 (1977-02-01), Schrider
patent: 4007280 (1977-02-01), Karrer
patent: 4017549 (1977-04-01), Karrer et al.
patent: 4031239 (1977-06-01), Schrider
patent: 4053631 (1977-10-01), Schrider
patent: 4057587 (1977-11-01), Karrer et al.
patent: 4060629 (1977-11-01), Karrer
patent: 4061683 (1977-12-01), Karrer et al.
patent: 4080470 (1978-03-01), Karrer
patent: 4089975 (1978-05-01), Wade et al.
patent: 4092365 (1978-05-01), Farooq et al.
patent: 4092421 (1978-05-01), Wade et al.
patent: 4097581 (1978-06-01), Farooq et al.
patent: 4100296 (1978-07-01), Farooq et al.
patent: 4160831 (1979-07-01), Laanio et al.
patent: 4160832 (1979-07-01), Laanio et al.
patent: 4166107 (1979-08-01), Miller et al.
patent: 4172146 (1979-10-01), Karrer
patent: 4173638 (1979-11-01), Nishiyama et al.
patent: 4187304 (1980-02-01), Immler et al.
patent: 4187305 (1980-02-01), Immler et al.
patent: 4199569 (1980-04-01), Chabala et al.
patent: 4225598 (1980-09-01), Brechbuhler et al.
patent: 4321388 (1982-03-01), Nishiyama et al.
patent: 4323582 (1982-04-01), Siegel et al.
patent: 4346171 (1982-08-01), Takiguchi et al.
patent: 4346177 (1982-08-01), Cochet et al.
patent: 4350706 (1982-09-01), Brouwer et al.
patent: 4399152 (1983-08-01), Brouwer et al.
patent: 4405552 (1983-09-01), Miesel
patent: 4473582 (1984-09-01), Greene et al.
patent: 4540578 (1985-09-01), Chou et al.
patent: 4547520 (1985-10-01), Ide et al.
patent: 4677127 (1987-06-01), Boger
patent: 4696974 (1987-09-01), Sulc et al.
patent: 4751223 (1988-06-01), Glamkowski et al.
patent: 4879292 (1989-11-01), Nishida et al.
patent: 4970222 (1990-11-01), Nishida et al.
patent: 4973589 (1990-11-01), Barnett et al.
patent: 4988824 (1991-01-01), Maulding et al.
Chemical Abstracts 102:57842e (1985).
Chemical Abstracts 102:61919c (1985).
Dean Karen A.
McGregor Martin L.
Virbac, Inc.
LandOfFree
Systemic control of parasites does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Systemic control of parasites, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Systemic control of parasites will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-958012